Trade Mark Journal No.2026/002 9 January 2026

WO0000001892264 (1,5,42)

Office of origin: Australia

Date of International Registration:27 October 2025
Date of designation in the UK: 27 October 2025
Image for mark 1892264_TIF GAIASO THERANOSTICS

International priority date claimed: 12 May 2025 (Australia) (2547160)
Class 1
Biological preparations for use in industry and science.
Class 5
Diagnostic, therapeutic, biological, biochemical, radioactive substances, active agents, and/or compositions, namely, diagnostic preparations for medical use, therapeutic preparations for medical use, namely, pharmaceutical preparations for the medical diagnosis or treatment of cancer.
Class 42
Scientific and technological services, namely, scientific research and analysis in the fields of pharmaceutical, diagnostic, or biochemical substances; scientific and technological services, namely, scientific research in the fields of the identification, further development, and use of biochemical, pharmaceutical, and diagnostic products; scientific laboratory services in the fields of molecular biological, biotechnological, biochemical or pharmaceutical products; research and development in the field of medical diagnostics and treatment using molecular biological, genetic engineering, biotechnological or biochemical methods, and in the field of identification, screening and development of pharmaceutically active components, and test methods and test kits.

GAIASO THERANOSTICS PTY LTD

Representative: Davies Collison Cave Pty Ltd, Level 28,, 500 Bourke Street, MELBOURNE VIC 3000, AUSTRALIA